| |
| |
|
| Insider
Information: |
Platt David |
| Relationship: |
CEO, Director, 10% Owner |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
46,736,274 |
|
|
Indirect Shares
|
20,133,018 |
|
|
| Direct
Value |
$7,800,000 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
66,869,292 |
|
|
| Total
Value |
$7,800,000 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Glycogenesys Inc |
GLGSQ |
Affiliate |
2003-08-27 |
709,000 |
2003-07-07 |
0 |
Premium* |
|
|
Galectin Therapeutics Inc |
GALT |
Chairman & CEO, Director |
2008-01-16 |
3,000,000 |
2008-01-16 |
0 |
Premium* |
|
|
US Rare Earth Minerals |
USMND |
CEO, Director, 10% Owner |
2021-11-19 |
43,027,274 |
2024-03-27 |
20,133,018 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
61 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| GALT |
Galectin Therapeutics Inc |
Chairman & CEO |
• • • |
2004-03-18 |
5 |
GD |
$0.00 |
$0 |
D/D |
5,000 |
0 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Chairman & CEO |
• • • |
2004-04-07 |
5 |
GD |
$0.00 |
$0 |
D/D |
7,379 |
0 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Chairman & CEO |
• • • |
2004-04-07 |
5 |
GA |
$0.00 |
$0 |
D/D |
7,379 |
0 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Chairman & CEO |
• • • |
2004-04-13 |
5 |
GD |
$0.00 |
$0 |
D/D |
3,441,868 |
0 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Chairman & CEO |
• • • |
2004-04-13 |
5 |
GA |
$0.00 |
$0 |
D/D |
3,441,868 |
0 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Chairman & CEO |
• • • |
2004-06-24 |
5 |
GD |
$0.00 |
$0 |
I/I |
5,000 |
1,090,000 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Chairman & CEO |
• • • |
2007-06-04 |
5 |
GD |
$0.00 |
$0 |
I/I |
200,000 |
0 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Chairman & CEO |
• • • |
2007-06-19 |
5 |
GD |
$0.00 |
$0 |
I/I |
200,000 |
0 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Chairman & CEO |
• • • |
2007-08-28 |
5 |
GD |
$0.00 |
$0 |
I/I |
400,000 |
0 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Chairman & CEO |
• • • |
2007-11-30 |
5 |
GD |
$0.00 |
$0 |
I/I |
400,000 |
0 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Chairman & CEO |
• • – |
2008-01-16 |
5 |
GD |
$0.00 |
$0 |
I/I |
327,468 |
0 |
0 |
- |
|
61 Records found
|
|
Page 3 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
